Module 543 Residual: 0.50
Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)
| Residual | Motif 1 e-value | Motif 2 e-value | Conditions | Genes | version |
|---|---|---|---|---|---|
| 0.50 | 7.6e-18 | 0.00000000013 | 78 | 32 | 20160204 |
| Motif 1 |
 |
|---|---|
| e-value: 7.6e-18 | |
| Motif 2 |
 |
| e-value: 0.00000000013 |
| MSMEG_5040 Transcriptional regulator, TetR family (Transcriptional regulator, TetR family protein) | MSMEG_0209 Ribonuclease inhibitor (Uncharacterized protein) |
| MSMEG_4461 Conserved hypothetical integral membrane protein | MSMEG_0831 Short chain dehydrogenase (Short-chain dehydrogenase/reductase SDR) (EC 1.1.1.100) |
| MSMEG_5489 50S ribosomal protein L32 | MSMEG_6709 Cyclopentanol dehydrogenase (EC 1.1.1.163) (Short-chain dehydrogenase/reductase SDR) (EC 1.1.1.-) |
| MSMEG_3336 Hydrolase | MSMEG_3416 Putative permease of the drug/metabolite transporter (DMT) superfamily (Uncharacterized protein) |
| MSMEG_6733 Hydrolase, carbon-nitrogen family protein | MSMEG_3253 Uncharacterized protein |
| MSMEG_0290 Diacylglycerol O-acyltransferase (EC 2.3.1.20) | MSMEG_3342 Uncharacterized protein |
| MSMEG_6545 Lipoprotein lpqD (EC 5.4.2.-) (Phosphoglycerate mutase family protein) | MSMEG_2523 Efflux ABC transporter, permease protein, putative (Uncharacterized protein) |
| MSMEG_0829 Exodeoxyribonuclease III (EC 3.1.11.2) (Exodeoxyribonuclease III protein XthA) (EC 3.1.11.2) | MSMEG_2522 Efflux ABC transporter, permease protein (Uncharacterized protein) |
| MSMEG_1386 Uncharacterized protein | MSMEG_2786 Hydrolase, alpha/beta fold family protein |
| MSMEG_1384 Uncharacterized protein | MSMEG_2525 Amino acid permease superfamily protein (Amino acid permease-associated region) |
| MSMEG_0882 Pyridoxamine 5'-phosphate oxidase-related, FMN-binding protein (Uncharacterized protein) | MSMEG_2524 ABC transporter related protein (ABC transporter, ATP-binding protein) |
| MSMEG_3988 Transcriptional regulator, AsnC family protein | MSMEG_3990 Major facilitator superfamily MFS_1 (Putative transporter) |
| MSMEG_3989 Peptidase M20D, amidohydrolase (EC 3.5.1.32) | MSMEG_4860 Hydrolase, alpha/beta fold family protein, putative |
| MSMEG_2297 | MSMEG_4859 Oxidoreductase, short chain dehydrogenase/reductase family protein (Short-chain dehydrogenase/reductase SDR) |
| MSMEG_5036 Conserved membrane protein in rhomboid family (Rhomboid family protein) | MSMEG_4887 Cytochrome P450 |
| MSMEG_5038 Cytochrome P450 CYP130 (Putative cytochrome P450 123) (EC 1.14.-.-) | MSMEG_4885 Uncharacterized protein |
Biological.replicate.5.of.6..negative.control
Bedaquiline.vs..DMSO.30min
Biological.replicate.5.of.7..falcarinol.treatment
WT.vs..DamtR.without.N_rep1
KO_log.phase_rep1
X4XR.rep1
Biological.replicate.5.of.7..panaxydol.treatment
M..smegmatis.Acid.NO.treated
Biological.replicate.4.of.6..negative.control
Plogcy5plogcy3slide110norm
X2XR.rep1
MB100pruR.vs..MB100..rep.3
Tet.CarD.vs.Control..Replicates.1..2..and.3.
dosR.WT_Replicate1
mc2155.pMind..vs.mc2155.pMind.6189.replicate.4
KO_log.phase_rep2
Wild.type.rep2.y
Wild.type.rep1.y
Wild.type.rep1.x
Biological.replicate.7.of.7..falcarinol.treatment
Biological.replicate.6.of.6..negative.control
Biological.replicate.1.of.6..isoniazid.treatment
Biological.replicate.7.of.7..ethambutol.treatment
Biological.replicate.1.of.7..ethambutol.treatment
Biological.replicate.6.of.6..kanamycin.treatment
Biological.replicate.3.of.7..falcarinol.treatment
rel.knockout.rep1
Biological.replicate.6.of.7..falcarinol.treatment
WT.vs..DglnR.N_starvation_dye.swap_rep2
Biological.replicate.3.of.7..ethambutol.treatment
Biological.replicate.3.of.6..isoniazid.treatment
X0.6..vs..50..air.saturation.Replicate.2
X0.6..vs..50..air.saturation.Replicate.5
Biological.replicate.6.of.7..ethambutol.treatment
WT.vs..DamtR.N.surplus_rep1
mc2155.vs.Dcrp1.replicate.2
M.smegmatis_mc2_155_dMSMEG_0166_study_mutant_rep1
Biological.replicate.5.of.6..kanamycin.treatment
Biological.replicate.3.of.6..negative.control
dcpA.knockout.rep2
dcpA.knockout.rep1
Biological.replicate.2.of.6..isoniazid.treatment
Biological.replicate.2.of.7..falcarinol.treatment
stphcy5plogcy3slide580norm
X2.5..vs..50..air.saturation.Replicate.4
X3dbfcy3plogcy5slide607norm
Biological.replicate.4.of.7..panaxydol.treatment
X4dbfcy5plogcy3slide480norm
X2.5..vs..50..air.saturation.Replicate.2
WT.with.vs..without.N_dye.swap_rep2
WT_stationary.phase_rep1
Biological.replicate.6.of.6..isoniazid.treatment
Biological.replicate.4.of.6..isoniazid.treatment
Biological.replicate.5.of.7..ethambutol.treatment
Slow.vs..Fast.Replicate.4
Stationary.cultures.control.without.induction.of.I.SceI.expression..T.0...Atc.
Biological.replicate.5.of.6..isoniazid.treatment
Slow.vs..Fast.Replicate.1
Slow.vs..Fast.Replicate.2
Biological.replicate.7.of.7..panaxydol.treatment
BatchCulture_LBTbroth_ExponentialPhase_Replicate2
dosR.WT_Replicate3
X3dbfcy5plogcy3slide603norm
mc2155.pMind..vs.mc2155.pMind.6189.replicate.2
Wild.type.rep3
X4dbfcy5plogcy3slide901norm
mc2155.pMind..vs.mc2155.pMind.6189.replicate.1
WT.with.vs..without.N_rep2
dosR.WT_Replicate4
Log.phase.cultures.induced.to.express.I.SceI.for.45.minutes..T.45...ATc.
X2XR.rep2
JR121..pJR29.VapC..vs..JR121..pJR230..VapBC..rep1
JR121..pJR29.VapC..vs..JR121..pJR230..VapBC..rep3
Plogcy5plogcy3slide113norm
M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep3
M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep2
M.smegmatis_mc2_155_dMSMEG_0166_study_wild.type_rep1
X4dbfcy3plogcy5slide903norm
Comments
Log in to post comments